Biofrontera Inc. (BFRI)
(Delayed Data from NSDQ)
$0.95 USD
-0.07 (-6.86%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.92 -0.03 (-3.16%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Biofrontera Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BFRI 0.95 -0.07(-6.86%)
Will BFRI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BFRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BFRI
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
BFRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
Other News for BFRI
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025 | BFRI ...
Biofrontera Inc. (BFRI) Announces Plan to Offer 13.6 Million Shares | BFRI Stock News
Biofrontera files to sell 13.6M shares of common stock by selling shareholders
Biofrontera Inc. files to sell 13.6M shares of common stock for holders
Biofrontera restructures relationship with Biofrontera AG, backed by $11M investment